Wnt proteins are secreted signaling molecules that regulate many fundamental aspects of cellular functions in embryogenesis and tissue homeostasis. Deregulated Wnt signaling has been implicated in many human diseases such as cancer, osteoporosis and degenerative disorders. The study of the mechanisms of Wnt signaling has critical importance for understanding basic biology and human health. Wnt signaling is initiated by two types of transmembrane receptors that constitute the Wnt receptor complex. One is a member of the Frizzled (Fz) family of serpentine receptors, while the other is a single transmembrane receptor belonging to the LDL receptor related protein (LRP) family, LRP5 or LRP6. In addition to Wnt proteins, many distinct extracellular ligands appear to engage the Fz and/or LRP5/6 receptors and activate or inhibit Wnt signaling during embryonic development and under pathological conditions. The relationships between these Wnt agonists/antagonists with Fz and LRP5/6 receptors remain poorly understood, and are the focus of this application. Three related aims for formulated.
Aim1 is to study R-spondin proteins, a novel family of agonists that activate Wnt signaling. R-spondin proteins have roles in vertebrate embryogenesis and are mutated in hereditary diseases. R-spondin proteins are also being developed as cancer therapeutic agents. But the relationships among R-spondin, Wnt and Fz-LRP5/6 receptors are debated and unresolved. Experiments are proposed to address these issues and to identify additional Rspo-binding factors/receptors.
Aim 2 is to study the mechanism and function of a novel transmembrane protein, M15, that inhibits Wnt/2-catenin signaling. We have performed a functional cDNA expression screen in Xenopus embryos for genes that promote anterior formation. We identified a novel transmembrane protein, termed M15, that functions as a potent Wnt antagonist. M15 exhibits specific expression in the Spemann's organizer and also during somitogenesis. We propose experiments to study the molecular mechanism of M15 in inhibition of Wnt signaling and the biological function of in head/anterior development and somite formation.
Aim 3 is to study M15L function and to identify additional novel cDNAs involved in anterior-posterior patterning. M15- like (M15L) is the other member of the M15 family we identified in Xenopus and human. It is a Wnt antagonist and has head-inducing activity in Xenopus embryos, but exhibits noticeable difference in Wnt inhibition specificity compared to M15. We plan to study the expression and function of M15L and uncover similar and/or distinct roles of M15 and M15L during Xenopus development. Additionally, based on our success with the isolation of M15, we plan to continue a more comprehensive functional cDNA expression screen for other novel genes that are involved in anterior-posterior patterning. These molecular and embryological experiments together will likely advance our understanding of the regulation of the Wnt receptor complex by novel agonists and antagonists in vertebrate development and human diseases.
Cell growth and differentiation are regulated by the interaction between extracellular signaling molecules and their receptors on the cell surface. Defects in this interaction often cause human cancers and diseases. This proposal aims to understand the molecular nature of the interaction between a key family of signaling molecules and their receptors that have been associated with many diseases.
|Guo, Chaoshe; Sun, Ye; Guo, Chunming et al. (2014) Dkk1 in the peri-cloaca mesenchyme regulates formation of anorectal and genitourinary tracts. Dev Biol 385:41-51|
|Reis, Alice H; Macdonald, Bryan T; Feistel, Kerstin et al. (2014) Expression and evolution of the Tiki1 and Tiki2 genes in vertebrates. Int J Dev Biol 58:355-62|
|Bazan, J Fernando; Macdonald, Bryan T; He, Xi (2013) The TIKI/TraB/PrgY family: a common protease fold for cell signaling from bacteria to metazoa? Dev Cell 25:225-7|
|Zebisch, Matthias; Xu, Yang; Krastev, Christos et al. (2013) Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 4:2787|
|Zhang, Xinjun; He, Xi (2013) PAF makes it EZ(H2) for *-catenin transactivation. Mol Cell 52:157-8|
|Liu, Chunming; He, Xi (2010) Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway. J Mol Cell Biol 2:70-3|
|Xu, Wenqing; He, Xi (2010) DEEP Insights through the DEP Domain. Structure 18:1223-5|
|Zhong, Hanbing; Zou, Haixia; Semenov, Mikhail V et al. (2009) Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling. Mol Biosyst 5:1356-60|
|MacDonald, Bryan T; Tamai, Keiko; He, Xi (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26|
|Semenov, Mikhail V; Zhang, Xinjun; He, Xi (2008) DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem 283:21427-32|
Showing the most recent 10 out of 15 publications